Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class ASSE: 603896

"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 3, 2026 · Issued by Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A

"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Resolutions of the 10th Meeting of the 5th Board of DirectorsAug 26
"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Change of Securities Affairs RepresentativeJul 8
"Zhejiang Shouxiangu Pharmaceutical Co., Ltd."Announcement on Conversion Result of "Shouxiangu 22 Convertible Bond" and Share ChangesJul 2
Announcement on Follow-up Rating Results of "Shouxiangu 22 Convertible Bonds" in 2026Jun 27

All Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A news releases